EuroHeart is an ESC initiative based on a collaboration between national registries and in collaboration with national cardiac societies. The aim of national registries is to continually monitor quality of care at national and local levels as a necessary prerequisite to improving care effectively. EuroHeart is predominantly designed for the benefit of patients, citizens and the planning of healthcare investments.

The EuroHeart initiative

The EuroHeart Initiative, led by the European Society of Cardiology (ESC), aims to improve cardiovascular care by fostering international collaboration and supporting high-quality data collection across healthcare systems.

Our Journey So Far:

• Pilot Phase (2019–2021):
  In July 2019, the ESC Board approved the launch of a two-year pilot phase across two to four countries to assess the feasibility of implementing EuroHeart in diverse healthcare systems.
• Consolidation Phase (2022–2024):
  Following the successful pilot phase, the ESC Board approved the consolidation phase in October 2022. This phase focused on maintaining and expanding the network of collaborating countries and concluded in December 2024.

What’s Next (From 2025 Onwards):

With the successful completion of the Pilot and Consolidation Phases, the EuroHeart Initiative is now entering its next chapter. This new phase will focus on:

• The publication of an Annual Report with data collected from each participating country.
• Strengthening the EuroHeart Network by increasing participation from more countries and healthcare institutions.

The future of EuroHeart:

• Expand to additional registry disease domains: Heart Failure and Atrial Fibrillation
• Federated Analysis of data: Leveraging cutting-edge analytical tools to extract actionable insights.
• Generate new evidence: Starting registry-based randomised clinical trials (R-RCT)

The EuroHeart Initiative remains dedicated to shaping the future of cardiovascular care through innovation, collaboration, and data-driven excellence.

Key features

Collaborative National Programmes:
Built on partnerships between national programmes using common data sets, standardised methodologies, and shared quality criteria.

Inclusive Governance:
Involves representatives from participating countries in the development process and all subcommittees.

Continuous Quality Improvement:
Enhances care quality through the ongoing collection and analysis of patient data for real-time improvements.

Standardised Data Sets and Quality Indicators:
Expands standardised data sets and quality indicators across key cardiovascular areas:

• ACS-PCI
• Heart Failure
• Atrial Fibrillation
• Valve Disease

Advanced Data Science Center:
Develops a Data Science Center to support collaborative research and advanced analytics in partnership with national registries.

Enhanced Registry IT Platform:
Offers an optional IT platform to support:

• • Device surveillance
  • Registry-based randomised clinical trials (R-RCT)
  • Flexible data integration

EuroHeart Executive Committee

Chair: Prof. Lars Wallentin

Deputy Chair: Prof. Eva Prescott

Members: Prof. Barbara Casadei, Prof. David Erlinge, Prof. Rajesh Kharabanda, Prof. Stefan James, Prof. Chris Gale, Prof. Aldo Maggioni, Sara Hansson.

ESC Representative: Aline Abravanel, Valentina Tursini

Operational Lead; Project manager: Adham Gharieb

Senior Advisor; Project manager: Ebba Bergman

Contact

For more details about the EuroHeart project, data standards, EuroHeart Registry IT platform and its development, or if you would like your country to participate in the EuroHeart project, please contact us by email.